Barotrauma in patients with severe coronavirus disease 2019—retrospective observational study
Authors:
Open Access
- 1 October 2023
- journal article
- research article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (10) , 5297-5306
Abstract
Background: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Although it is known that the COVID-19 acute respiratory distress syndrome (ARDS) is associated with higher incidence of pulmonary barotrauma, unique mechanisms causing the aforementioned complication are still to be investigated. The goal of this research was to investigate the incidence of barotrauma among COVID-19 patients treated in the intensive care unit (ICU) and to examine different clinical outcomes among those subjects. Methods: This retrospective observational cohort study included adult COVID-19 patients admitted to ICU from September 1, 2020, to February 28, 2022. All admitted subjects received invasive respiratory support. Subjects were divided into two groups based on occurrence of pulmonary barotrauma. Data were collected from available electronical medical records. Results: In the study period, a total of 900 subjects met inclusion criteria. Pulmonary barotrauma occurred in 88 (9.8%) of them. Subcutaneous emphysema developed in 73 (83%), pneumomediastinum in 68 (77.3%) and pneumothorax in 54 (61.4%) subjects. A small group of subjects developed less common complications like pneumoperitoneum (8 subjects, 9.1%) and pneumopericardium (2 subjects, 2.3%). Survival rate was higher in control than in barotrauma group [396 (48.8%) vs. 22 (25.0%), P2/FiO2 ratio on admission, duration of non-invasive respiratory support before mechanical ventilation, duration of mechanical ventilation and duration of ICU and hospital stay, all in favour of control group. Conclusions: Development of barotrauma in patients with severe forms of COVID-19 disease and in need of respiratory support is associated with longer ICU and hospital stay as well as lower survival rates at hospital discharge. Further efforts are needed in understanding mechanism in developing barotrauma and finding new prevention and treatment options.Keywords
This publication has 29 references indexed in Scilit:
- Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?ERJ Open Research, 2020
- Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation – A Case-Control StudyJournal of Intensive Care Medicine, 2020
- Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort StudyCritical Care Explorations, 2020
- COVID ‐19 acute respiratory distress syndrome ( ARDS ): clinical features and differences from typical pre‐ COVID ‐19 ARDSMedical Journal of Australia, 2020
- Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in WuhanCritical Care, 2020
- COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Spontaneous pneumomediastinum and Macklin effect: Overview and appearance on computed tomographyWorld Journal of Radiology, 2014
- Ventilator-Induced Lung InjuryNew England Journal of Medicine, 2013
- Acute respiratory distress syndrome: new definition, current and future therapeutic options2013
- ARDS. History, definitions, and physiology.1998